Our read is that you should eat more protein to build muscle, especially when combined with resistance training, to combat age-related muscle loss and improve overall health.
Our read is that increasing protein intake, particularly in conjunction with resistance training, is well-supported for building and maintaining muscle mass, especially as we age. Experts like Rhonda Patrick and Peter Attia emphasize that adequate protein intake is crucial for countering age-related muscle loss and anabolic resistance.
While the timing of protein intake around workouts has been debated, the consensus leans towards total daily protein intake being the most significant factor for muscle growth. However, a diet high in refined carbohydrates combined with high protein intake may accelerate the growth of damaged cells, suggesting the importance of overall dietary context.
Rhonda Patrick suggests that increasing protein intake from 1.2 to 1.6 grams per kilogram of body weight per day, particularly for individuals engaged in resistance training, can significantly increase muscle mass and strength. She also advises consuming protein immediately post-resistance training due to increased muscle sensitivity to amino acids, though she also notes that delaying intake by 2-3 hours yields similar gains. Peter Attia mentions Dr. Bernstein's method of covering protein with regular human insulin due to its slower onset and longer duration.
Rhonda Patrick cautions that a diet high in refined carbohydrates and high protein intake can accelerate the growth of damaged cells. She also notes that the anabolic window concept is outdated, and delaying protein intake by 2-3 hours post-resistance training yields similar gains in hypertrophy and strength. Paul Saladino warns that performance in endurance athletes will suffer on ketogenic diets if protein intake is insufficient, glycogen stores are not full, and ketones are chased. He also suggests that studies linking mTOR and cancer with protein intake are often flawed due to the use of animal models. Peter Attia states that the risk of cancer associated with higher protein intake needs to be quantified and compared to the risk of sarcopenia. He also notes that dietary recommendations, such as protein intake for ketosis, vary significantly between individuals.
The verdict could change if more robust randomized controlled trials, particularly with larger sample sizes comparable to pharmaceutical studies, provided conflicting evidence regarding the efficacy or safety of increased protein intake for muscle building and longevity. Additionally, further research clarifying the long-term risks of higher protein intake, especially concerning cancer, would be crucial. Peter Attia notes that randomized controlled trials in nutrition, particularly for protein intake, often have significantly smaller sample sizes compared to pharmaceutical studies.
The effect size is large enough to matter clinically, not just statistically.
Mechanistic and trial evidence converge on a real, replicable effect.
Benefits hold across the populations where it's been tested.
Mechanistic and trial evidence converge on a real, replicable effect.
The effect size is large enough to matter clinically, not just statistically.
The headline effect shrinks once you account for trial quality.
The headline effect shrinks once you account for trial quality.
The headline effect shrinks once you account for trial quality.
Most of the support comes from short or small studies.
Most of the support comes from short or small studies.